F
F. L. Johnson
Researcher at University of Washington
Publications - 19
Citations - 3684
F. L. Johnson is an academic researcher from University of Washington. The author has contributed to research in topics: Aplastic anemia & Transplantation. The author has an hindex of 13, co-authored 19 publications receiving 3651 citations. Previous affiliations of F. L. Johnson include Providence Regional Medical Center Everett & Puget Sound Blood Center.
Papers
More filters
Journal ArticleDOI
Bone-marrow transplantation (first of two parts).
Thomas Ed,Rainer Storb,Clift Ra,Alexander Fefer,F. L. Johnson,Paul E. Neiman,Lerner Kg,Glucksberg H,C. D. Buckner +8 more
Journal ArticleDOI
Marrow transplantation for acute nonlymphoblastic leukemia in first remission.
Thomas Ed,Buckner Cd,Reginald A. Clift,A Fefer,F. L. Johnson,Paul E. Neiman,George E. Sale,Jean E. Sanders,Jack W. Singer,Howard M. Shulman,Rainer Storb,Paul L. Weiden +11 more
TL;DR: This work has reported the application of this approach combined with intensive chemotherapy treatment for bone marrow transplantation without regard to marrow toxicity in patients with central giant cell granuloma.
Journal ArticleDOI
Allogeneic marrow grafting for treatment of aplastic anemia.
Rainer Storb,Thomas Ed,C. D. Buckner,Clift Ra,F. L. Johnson,Alexander Fefer,Glucksberg H,Eloise R. Giblett,Lerner Kg,Paul E. Neiman +9 more
TL;DR: The results show that normal stem cells will repopulate the marrow in patients with aplastic anemia and demonstrate that long-term stable chimerism is possible in man.
Journal ArticleDOI
Marrow transplantation for patients with acute lymphoblastic leukemia in remission.
Thomas Ed,Jean E. Sanders,Nancy Flournoy,F. L. Johnson,Buckner Cd,Clift Ra,A Fefer,BW Goodell,Rainer Storb,Paul L. Weiden +9 more
TL;DR: In this paper, a proportional hazards regression analysis was used to evaluate various parameters known to be of prognostic importance in the chemotherapy of acute lymphoblastic leukemia (ALL) patients.
Journal ArticleDOI
Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle.
R Storb,Thomas Ed,Paul L. Weiden,C. D. Buckner,C. D. Buckner,C. D. Buckner,Clift Ra,Clift Ra,Clift Ra,Alexander Fefer,Alexander Fefer,Alexander Fefer,Leonor P Fernando,Leonor P Fernando,Leonor P Fernando,Eloise R. Giblett,Eloise R. Giblett,Eloise R. Giblett,BW Goodell,BW Goodell,BW Goodell,F. L. Johnson,F. L. Johnson,F. L. Johnson,Lerner Kg,Lerner Kg,Lerner Kg,Paul E. Neiman,Paul E. Neiman,Paul E. Neiman,Jean E. Sanders,Jean E. Sanders,Jean E. Sanders +32 more
TL;DR: The long-term survival of 41% of the patients in the present study is similar to that achieved in the first 24 patients, and confirms the importance of marrow transplantation for the treatment of severe aplastic anemia.